Fibrosis and mortality in patients with dilated cardiomyopathy.

[1]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[2]  N. Danchin,et al.  Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. , 1997, European heart journal.

[3]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[4]  D. Linker,et al.  Prediction of mortality in patients with heart failure and systolic dysfunction , 2008, Current cardiology reports.

[5]  M. Emdin,et al.  Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy. , 2012, International journal of cardiology.

[6]  Arjun K Venkatesh,et al.  The growing role of emergency departments in hospital admissions. , 2012, The New England journal of medicine.

[7]  Margaret S Pepe,et al.  Problems with risk reclassification methods for evaluating prediction models. , 2011, American journal of epidemiology.

[8]  Tevfik F Ismail,et al.  Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy , 2011, Heart.

[9]  N. Cook,et al.  Net reclassification improvement: a link between statistics and clinical practice , 2013, European Journal of Epidemiology.

[10]  D. Pennell,et al.  Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non‐ischaemic dilated cardiomyopathy , 2013, European journal of heart failure.

[11]  Tevfik F Ismail,et al.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.

[12]  Ewout Steyerberg,et al.  Net reclassification improvement and decision theory , 2009, Statistics in medicine.

[13]  James G. Adams.  Emergency department overuse: perceptions and solutions. , 2013, JAMA.

[14]  M. Cheitlin,et al.  BNP-Guided vs Symptom-Guided Heart Failure Therapy: The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) Randomized Trial , 2010 .

[15]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[16]  H. Kestler,et al.  Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy , 2009, European heart journal.